Skip to main content
. 2021 Jun 16;40:196. doi: 10.1186/s13046-021-01984-w

Table 3.

UM patients characteristics

Code LB Sex Age (Y) Location ctDNA FA Lesion T category, AJCC classification FU Rx
21 F 70 Choroid 4.3 9.5 3 × 10 × 9 2 77 P
22 F 60 Choroid 2.8 3.7 9 × 1.9 × 5.7 4 50 P
27 F 68 Choroid 3.0 8 9.7  × 9  × 3.3 2 39 P+
28 F 48 Choroid 1.9 2.8 7.5 × 5.5 × 2.1 1 260 TT
29 M 62 Iris 12.8 2.7 3.4 × 3.8 × 1.3 1 37 PR
30 M 69 Choroid 2.3 17 16 × 16 × 8 3 61 P+
31 M 85 Choroid 29.3 33 9.5 × 8.5 × 3.1 3 229 P
32 M 63 Choroid 2.1 2.6 11.5 × 12 × 2.8 1 190 P+
33 F 82 Choroid 26.4 7 2.2 × 1 × 1 2 37 P+
36 M 37 Choroid 31.6 3.1 13.3 × 10.9 × 5 2 1 P
40 F 38 Choroid 3.2 1.6 10.7 × 8.5 × 3.0 1 92 SR
41 M 71 Choroid 9.8 13.5 8.2 × 8.7 × 4.3 2 164 P
42 F 38 Choroid 0.7 4 13 × 9.5 × 2.3 2 55 P+
43 M 51 Choroid 9.0 5 8.4 × 9.1 × 2.8 1 150 P

+ = anti-VEGF treatment; AJCC AJCC classification; ctDNA (molecules/ml); FA percentage of fractional abundance; FU follow-up time (months); Lesion Lesion size (small diameter x large diameter x thickness) (in mm); P Plaque radiotherapy; PR Proton beam radiotherapy; Rx Treatment; SR Stereotactic radiosurgery; T T category; TT Transpupillary thermotherapy